Activity of protein kinase C is important for 3α,5α-THP's actions at dopamine type 1-like and/or GABAA receptors in the ventral tegmental area for lordosis of rats
article
OA: green
CC0
⤵ 3 in-corpus citations
Abstract
In the ventral tegmental area, progestogens facilitate sexual receptivity of rodents via actions at dopamine type 1-like and/or gamma-aminobutyric acid type A receptors and activation of downstream signal transduction molecules. In the present study, we investigated whether effects of progesterone's metabolite, 3alpha,5alpha-THP, to enhance lordosis via actions at these receptors in the ventral tegmental area requires phospholipase C-dependent protein kinase C. The objective of this study was to test the hypothesis that: if progestogens' actions through dopamine type 1-like and/or gamma-aminobutyric acid type A receptors in the ventral tegmental area for lordosis require protein kinase C, then inhibiting protein kinase C in the ventral tegmental area should reduce 3alpha,5alpha-THP-facilitated lordosis and its enhancement by dopamine type 1-like or gamma-aminobutyric acid type A receptor agonists. Ovariectomized, estradiol (E(2); 10 microg s.c. at h 0)-primed rats were tested for their baseline lordosis responses and then received a series of three infusions to the ventral tegmental area: first, bisindolylmaleimide (75 nM/side) or vehicle; second, SKF38393 (100 ng/side), muscimol (100 ng/side), or vehicle; third, 3alpha,5alpha-THP (100, 200 ng/side) or vehicle. Rats were pre-tested for lordosis and motor behavior and then tested for lordosis after each infusion and 10 and 60 min after the last infusion. Rats were tested for motor behavior following their last lordosis test. As has been previously demonstrated, 3alpha,5alpha-THP infusions to the ventral tegmental area increased lordosis and effects were further enhanced by infusions of SKF38393 and muscimol. Infusions of bisindolylmaleimide to the ventral tegmental area attenuated 3alpha,5alpha-THP-, SKF38393-, and/or muscimol-facilitated lordosis. Effects on lordosis were not solely due to changes in general motor behavior. Thus, 3alpha,5alpha-THP's actions in the ventral tegmental area through membrane receptors may require activity of protein kinase C.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors 2004
- In the Ventral Tegmental Area, Progestins’ Membrane-Mediated Actions for Lordosis of Hamsters and Rats Involve Protein Kinase A 2006
- Fluoxetine May Influence Lordosis of Rats through Effects on Midbrain 3α,5α‐THP Concentrations 2003
- A Potential Role of Cyclic GMP in the Regulation of Lordosis Behavior of Female Rats 1997
Cited by (3)
- Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint 2011
- Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint II. Role of progesterone metabolites 2011
- Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124 2014
References (83)
- A Potential Role of Cyclic GMP in the Regulation of Lordosis Behavior of Female Rats via openalex
- Fluoxetine May Influence Lordosis of Rats through Effects on Midbrain 3α,5α‐THP Concentrations via openalex
- In the Ventral Tegmental Area, Progestins’ Membrane-Mediated Actions for Lordosis of Hamsters and Rats Involve Protein Kinase A via openalex
- Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors via openalex
- W1965616042 via openalex
- W1966009307 via openalex
- W1970503530 via openalex
- W1970541268 via openalex
- W1971408287 via openalex
- W1971694649 via openalex
- W1973077501 via openalex
- W1974297394 via openalex
- W1977309548 via openalex
- W1978007828 via openalex
- W1978087801 via openalex
- W1980185682 via openalex
- W1980598448 via openalex
- W1984571490 via openalex
- W1989715687 via openalex
- W1989886426 via openalex
- W1994913081 via openalex
- W1996257723 via openalex
- W1997173932 via openalex
- W1998482063 via openalex
- W2000668515 via openalex
- W2002618947 via openalex
- W2002834809 via openalex
- W2007938469 via openalex
- W2009415563 via openalex
- W2011551179 via openalex
- W2014261005 via openalex
- W2018072064 via openalex
- W2018948493 via openalex
- W2021481513 via openalex
- W2024822444 via openalex
- W2027689472 via openalex
- W2028466691 via openalex
- W2028496605 via openalex
- W2037631502 via openalex
- W2042529247 via openalex
- W2044011700 via openalex
- W2045623258 via openalex
- W2047114909 via openalex
- W2054613803 via openalex
- W2056802543 via openalex
- W2058204822 via openalex
- W2062650600 via openalex
- W2065379249 via openalex
- W2068352644 via openalex
- W2070628627 via openalex
- W2071170105 via openalex
- W2073340336 via openalex
- W2073971076 via openalex
- W2077678165 via openalex
- W2078323034 via openalex
- W2080503049 via openalex
- W2083447043 via openalex
- W2092401349 via openalex
- W2092724204 via openalex
- W2094861520 via openalex
- W2108754858 via openalex
- W2127028633 via openalex
- W2127288848 via openalex
- W2127738766 via openalex
- W2129711624 via openalex
- W2130854580 via openalex
- W2131882459 via openalex
- W2133617210 via openalex
- W2134195901 via openalex
- W2134355904 via openalex
- W2140694826 via openalex
- W2164183982 via openalex
- W2165880831 via openalex
- W2285071408 via openalex
- W2339770802 via openalex
- W2412733667 via openalex
- W2417335759 via openalex
- W4406061022 via openalex
- W1555899391 via openalex
- W6641111910 via openalex
- W1788041309 via openalex
- W1961990310 via openalex
- W1964328431 via openalex
Cited by (3)
- Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124 2014
- Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint 2011
- Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint II. Role of progesterone metabolites 2011
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK